166 related articles for article (PubMed ID: 10227052)
1. Lycopene and 1,25-dihydroxyvitamin D3 cooperate in the inhibition of cell cycle progression and induction of differentiation in HL-60 leukemic cells.
Amir H; Karas M; Giat J; Danilenko M; Levy R; Yermiahu T; Levy J; Sharoni Y
Nutr Cancer; 1999; 33(1):105-12. PubMed ID: 10227052
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effects of curcumin on all-trans retinoic acid- and 1 alpha,25-dihydroxyvitamin D3-induced differentiation in human promyelocytic leukemia HL-60 cells.
Liu Y; Chang RL; Cui XX; Newmark HL; Conney AH
Oncol Res; 1997; 9(1):19-29. PubMed ID: 9112257
[TBL] [Abstract][Full Text] [Related]
3. Carnosic acid inhibits proliferation and augments differentiation of human leukemic cells induced by 1,25-dihydroxyvitamin D3 and retinoic acid.
Steiner M; Priel I; Giat J; Levy J; Sharoni Y; Danilenko M
Nutr Cancer; 2001; 41(1-2):135-44. PubMed ID: 12094616
[TBL] [Abstract][Full Text] [Related]
4. Lycopene interferes with cell cycle progression and insulin-like growth factor I signaling in mammary cancer cells.
Karas M; Amir H; Fishman D; Danilenko M; Segal S; Nahum A; Koifmann A; Giat Y; Levy J; Sharoni Y
Nutr Cancer; 2000; 36(1):101-11. PubMed ID: 10798222
[TBL] [Abstract][Full Text] [Related]
5. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.
Elstner E; Linker-Israeli M; Umiel T; Le J; Grillier I; Said J; Shintaku IP; Krajewski S; Reed JC; Binderup L; Koeffler HP
Cancer Res; 1996 Aug; 56(15):3570-6. PubMed ID: 8758928
[TBL] [Abstract][Full Text] [Related]
6. 1alpha,25-dihydroxyvitamin D3 and bryostatin-1 synergize to induce monocytic differentiation of NB4 acute promyelocytic leukemia cells by modulating cell cycle progression.
Clark CS; Konyer JE; Meckling KA
Exp Cell Res; 2004 Mar; 294(1):301-11. PubMed ID: 14980523
[TBL] [Abstract][Full Text] [Related]
7. 24-Oxo metabolites of vitamin D3 analogues: disassociation of their prominent antileukemic effects from their lack of calcium modulation.
Shiohara M; Uskokovic M; Hisatake J; Hisatake Y; Koike K; Komiyama A; Koeffler HP
Cancer Res; 2001 Apr; 61(8):3361-8. PubMed ID: 11309293
[TBL] [Abstract][Full Text] [Related]
8. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
9. Lycopene is a more potent inhibitor of human cancer cell proliferation than either alpha-carotene or beta-carotene.
Levy J; Bosin E; Feldman B; Giat Y; Miinster A; Danilenko M; Sharoni Y
Nutr Cancer; 1995; 24(3):257-66. PubMed ID: 8610045
[TBL] [Abstract][Full Text] [Related]
10. Induction of the differentiation of HL-60 promyelocytic leukemia cells by curcumin in combination with low levels of vitamin D3.
Sokoloski JA; Shyam K; Sartorelli AC
Oncol Res; 1997; 9(1):31-9. PubMed ID: 9112258
[TBL] [Abstract][Full Text] [Related]
11. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells.
Kubota T; Koshizuka K; Koike M; Uskokovic M; Miyoshi I; Koeffler HP
Cancer Res; 1998 Aug; 58(15):3370-5. PubMed ID: 9699668
[TBL] [Abstract][Full Text] [Related]
12. The role of granulocyte-macrophage colony-stimulating factor in induction of monocytic differentiation of HL-60 cells: synergistic interaction with 1 alpha, 25-dihydroxyvitamin D3 and interferon-gamma in inducing interleukin-1 beta.
Nakamaki T; Kawakami K; Sato S; Hino K; Tomoyasu S; Tsuruoka N; Honma Y; Hozumi M
Anticancer Res; 1992; 12(5):1331-7. PubMed ID: 1444189
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor beta and dexamethasone cooperatively enhance c-jun gene expression and inhibit the growth of human monocytoid leukemia cells.
Kanatani Y; Kasukabe T; Okabe-Kado J; Hayashi S; Yamamoto-Yamaguchi Y; Motoyoshi K; Nagata N; Honma Y
Cell Growth Differ; 1996 Feb; 7(2):187-96. PubMed ID: 8822202
[TBL] [Abstract][Full Text] [Related]
14. Growth inhibition and differentiation in HL-60 leukemia cells induced by 1,25-dihydroxyvitamin D3 and tumor necrosis factor alpha.
Wang SY; Chen LY; Wang SJ; Lin CK; Ho CK
Exp Hematol; 1991 Nov; 19(10):1025-30. PubMed ID: 1915703
[TBL] [Abstract][Full Text] [Related]
15. Lycopene and other carotenoids inhibit estrogenic activity of 17beta-estradiol and genistein in cancer cells.
Hirsch K; Atzmon A; Danilenko M; Levy J; Sharoni Y
Breast Cancer Res Treat; 2007 Aug; 104(2):221-30. PubMed ID: 17051425
[TBL] [Abstract][Full Text] [Related]
16. Effects of acyclo-retinoic acid and lycopene on activation of the retinoic acid receptor and proliferation of mammary cancer cells.
Ben-Dor A; Nahum A; Danilenko M; Giat Y; Stahl W; Martin HD; Emmerich T; Noy N; Levy J; Sharoni Y
Arch Biochem Biophys; 2001 Jul; 391(2):295-302. PubMed ID: 11437362
[TBL] [Abstract][Full Text] [Related]
17. Lycopene induces cell growth inhibition by altering mevalonate pathway and Ras signaling in cancer cell lines.
Palozza P; Colangelo M; Simone R; Catalano A; Boninsegna A; Lanza P; Monego G; Ranelletti FO
Carcinogenesis; 2010 Oct; 31(10):1813-21. PubMed ID: 20699249
[TBL] [Abstract][Full Text] [Related]
18. [Cell differentiation and down regulation of nm23 gene expression in HL-60 cells induced by 1,25 dihydroxyvitamin D3].
Zhu N; Lu Q; Zhou Y
Zhonghua Xue Ye Xue Za Zhi; 2001 Dec; 22(12):639-41. PubMed ID: 16200712
[TBL] [Abstract][Full Text] [Related]
19. Side-chain modified vitamin D analogs require activation of both PI 3-K and erk1,2 signal transduction pathways to induce differentiation of human promyelocytic leukemia cells.
Marcinkowska E; Kutner A
Acta Biochim Pol; 2002; 49(2):393-406. PubMed ID: 12362981
[TBL] [Abstract][Full Text] [Related]
20. The novel analog 1,24(S)-dihydroxyvitamin D2 is as equipotent as 1,25-dihydroxyvitamin D3 in growth regulation of cancer cell lines.
Levy Y; Knutson JC; Bishop C; Shany S
Anticancer Res; 1998; 18(3A):1769-75. PubMed ID: 9673403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
